Stay updated with breaking news from Ballarat health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tragedies spark Grampians Health policy and training changes | The Ararat Advertiser araratadvertiser.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from araratadvertiser.com.au Daily Mail and Mail on Sunday newspapers.
COMPANY NEWS: global one, a leading provider of next-generation technology solutions, has partnered with Insentra, a global channel-only services prov...
More healthy food on menu for Ballarat pools miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Gambling Harm Minimisation Policy adopted miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Victoria experiencing baby boom due after months under COVID-19 lockdown 9news.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 9news.com.au Daily Mail and Mail on Sunday newspapers.
A global shortage of syringes could hamper Australia's coronavirus vaccine rollout by causing thousands of doses to be wasted. The Pfizer vaccine, which started its rollout on Sunday morning, uses a custom-made low dead-space syringe, which Australia has ordered. These syringes can extract an extra sixth dose from a vial of the vaccine, whereas standard syringes can only get five. Pictured: Medical staff work at a pop-up Covid-19 testing site in Brighton, Melbourne on Saturday, February 6 The Pfizer vaccine, which started its rollout on Sunday morning, uses a custom-made low dead-space syringe, which Australia has ordered 'Even with a steady hand and a sharp eye, often you can't get out that last drop,' Mike Toole from the Burnet Institute in Melbourne told the Herald Sun.